Search Results 531-540 of 16992 for pharmacogenetics
Overview · High-throughput systems to identify cell-targeting ligands to target drugs, diagnostics, vaccines and gene delivery vectors. · Developing genetic and ...
Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread. Stereotactic radiosurgery is a ...
The Mayo Clinic Center for Individualized Medicine has achieved a milestone, finishing study recruitment after enrolling more than 100,000 participants in a ...
Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s.
About this study. The purpose of this study is to determine if robotic biopsies provide sufficient material for whole genomics and transcriptomics, ...
The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without ...
The purpose of this retrospective and prospective study is to evaluate tissue bank from donors and recipients who underwent heart and lung transplant in order ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.